Efficacy and Safety of the Selective α(1A)-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in Korea

PURPOSE: To evaluate the efficacy and safety of silodosin 8 mg once daily in a 12-week treatment of subjects with severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: A total of 100 subjects from 10 urology centers in Korea were includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Ki Hak, Song, Phil Hyun, Yang, Dae Yul, Park, Nam Cheol, Kim, Soo Woong, Lee, Sung Won, Kim, Sae Woong, Moon, Du Geon, Park, Jong Kwan, Ahn, Tai Young, Park, Kwangsung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026660/
https://www.ncbi.nlm.nih.gov/pubmed/24868338
http://dx.doi.org/10.4111/kju.2014.55.5.335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026660/
https://www.ncbi.nlm.nih.gov/pubmed/24868338
http://dx.doi.org/10.4111/kju.2014.55.5.335

Ejemplares similares